Miliary Dermatitis Cat: Comprehensive Veterinary Reference Guide
Quick Q&A
Question: What is miliary dermatitis in cats and what causes it?
Answer: Feline miliary dermatitis is a common skin reaction pattern characterized by multiple small, crusty papules (resembling millet seeds) that are intensely pruritic. It is not a specific disease but a cutaneous response to various underlying causes, most commonly flea allergy dermatitis (FAD). Other frequent aetiologies include food hypersensitivity, atopic dermatitis, and ectoparasite infestations.
Introduction
Miliary dermatitis (also known as papulocrustous dermatitis or "scabby cat disease") represents one of the most common dermatological presentations in feline practice. The term "miliary" derives from the Latin milium meaning millet seed, describing the characteristic small (1-2 mm) crusted papules that can be palpated rather than visualized in many cases. This condition is not a diagnosis in itself but rather a cutaneous reaction pattern with multiple potential underlying causes [3][28].
The clinical significance of miliary dermatitis extends beyond its cosmetic appearance. Affected cats experience significant pruritus, which can lead to self-induced alopecia, excoriation, and secondary bacterial infections. Furthermore, the condition often signals an underlying hypersensitivity disorder or systemic disease requiring comprehensive diagnostic investigation.
This comprehensive veterinary reference guide aims to provide clinicians, veterinary students, and dedicated pet owners with an exhaustive, evidence-based overview of feline miliary dermatitis. We will explore its aetiology, pathophysiology, diagnostic approach, treatment strategies, and long-term management, drawing upon the latest scientific literature and international veterinary guidelines.
Definition and Clinical Presentation
What is Miliary Dermatitis?
Miliary dermatitis is a descriptive term for a cutaneous reaction pattern characterized by the presence of multiple, small, erythematous papules topped with crusts. These lesions are typically 1-2 mm in diameter and are most easily detected by palpation (feeling like fine sandpaper or small scabs) rather than by visual inspection alone [28][30].
The condition is intensely pruritic, and affected cats often exhibit excessive grooming, scratching, and biting at the skin. This self-trauma can lead to secondary alopecia, excoriation, and lichenification (thickening of the skin) in chronic cases.
Clinical Signs and Lesion Distribution
The distribution of miliary dermatitis lesions can provide important diagnostic clues. While lesions can appear anywhere on the body, certain patterns are more commonly associated with specific underlying causes:
- Dorsal lumbosacral region and tail head: Strongly associated with flea allergy dermatitis (FAD) [7][15]
- Head, neck, and pinnae: Frequently seen in food hypersensitivity and atopic dermatitis [6][8]
- Ventral abdomen and medial thighs: Common in atopic dermatitis and contact hypersensitivity [58]
- Generalized distribution: May indicate systemic disease, drug reaction, or severe environmental allergy
A recent study using a modified SCORing Feline Allergic Dermatitis scale (mSCORFAD) found that in cats with a documented flea burden, the most common reaction pattern was self-induced alopecia on the ventral abdomen, while miliary dermatitis was most strongly associated with the cervical region [7].
The Pruritus Threshold Concept
Understanding the pruritus threshold is essential for managing miliary dermatitis. Each cat has an individual threshold for pruritus, determined by genetic predisposition and environmental factors. When the cumulative effect of multiple triggers (allergens, parasites, infections) exceeds this threshold, clinical signs become apparent. This concept explains why some cats with low-level allergen exposure remain asymptomatic while others develop severe dermatitis [58].
Aetiology and Pathophysiology
Miliary dermatitis is a cutaneous reaction pattern rather than a specific disease entity. The underlying causes can be broadly categorized into hypersensitivity disorders, ectoparasite infestations, infectious diseases, and miscellaneous conditions.
Hypersensitivity Disorders
Hypersensitivity reactions are the most common underlying cause of miliary dermatitis, accounting for the majority of cases.
Flea Allergy Dermatitis (FAD)
Flea allergy dermatitis is the single most common cause of miliary dermatitis in cats worldwide [7][15]. FAD is a Type I (immediate) and Type IV (delayed) hypersensitivity reaction to antigens present in flea saliva, particularly the protein Ctenocephalides felis. The condition is more common in regions with warm, humid climates where flea populations thrive.
Clinical studies have shown that even a single flea bite can trigger a significant allergic reaction in sensitized cats. The classic distribution for FAD includes the dorsal lumbosacral region, tail head, and caudomedial thighs, although miliary dermatitis can occur in any location [7][14].
Food Hypersensitivity (Adverse Food Reaction)
Adverse food reactions (AFR), often termed food allergy or food hypersensitivity, are the second most common cause of miliary dermatitis [8][10]. Unlike true immunological food allergies, many cases represent food intolerances with non-immunological mechanisms. Common protein sources include beef, dairy, chicken, fish, and lamb. Carbohydrate sources and additives can also be implicated.
Food hypersensitivity can present at any age and is not typically seasonal. Affected cats may show miliary dermatitis on the head, neck, and pinnae, although generalized distribution is also common. Concurrent gastrointestinal signs (vomiting, diarrhoea, or both) are present in 10-30% of cases [8][21].
Feline Atopic Dermatitis (FAD)
Feline atopic dermatitis (also known as non-flea, non-food hypersensitivity dermatitis) is a chronic, pruritic, inflammatory skin disease associated with environmental allergens such as house dust mites, pollens, and moulds [6][58]. The condition is believed to have both genetic and environmental components.
The diagnosis of feline atopic dermatitis is one of exclusion, made after ruling out flea allergy, food hypersensitivity, and other causes of miliary dermatitis. Clinical signs may be seasonal or non-seasonal depending on the allergens involved. The age of onset is typically between 6 months and 5 years [6][58].
Ectoparasite Infestations
Various ectoparasites can directly cause or contribute to miliary dermatitis through their feeding activities and the host's inflammatory response.
Otodectes cynotis (Ear Mites)
Otodectes cynotis infestations are a well-recognized cause of miliary dermatitis, particularly affecting the head, neck, and pinnae [1]. While ear mites primarily inhabit the external ear canal, they can migrate to other body areas, especially in cats with heavy infestations. The intense pruritus associated with ear mite infestation can lead to widespread miliary dermatitis and self-induced alopecia.
Cheyletiella spp. (Walking Dandruff)
Cheyletiella mites are highly contagious ectoparasites that cause a condition known as "walking dandruff." Infested cats develop scaling, crusting, and miliary dermatitis, particularly along the dorsum. The mites are zoonotic and can cause transient dermatitis in humans.
Other Mites and Lice
Notoedres cati (feline scabies), Demodex cati, and Felicola subrostratus (biting lice) can all cause miliary dermatitis in affected cats. These infestations are less common but should be considered in cats with appropriate exposure history and clinical signs.
Infectious Causes
Dermatophytosis
Dermatophyte infections, most commonly caused by Microsporum canis, can present with miliary dermatitis, especially in kittens and immunocompromised cats [13]. The classic ringworm lesions (circular areas of alopecia with scaling and crusting) may be present, but atypical presentations with miliary dermatitis alone are not uncommon.
Malassezia Dermatitis
Malassezia pachydermatis and other Malassezia species are part of the normal cutaneous mycobiome of cats. However, in the presence of underlying disease (particularly allergic dermatitis), these yeasts can proliferate and cause secondary Malassezia dermatitis, which may manifest as miliary dermatitis, greasy seborrhoea, and ceruminous otitis [48].
Bacterial Pyoderma
While primary bacterial pyoderma is rare in cats compared to dogs, secondary bacterial infections (most commonly with Staphylococcus felis or Staphylococcus pseudintermedius) can complicate existing miliary dermatitis and exacerbate pruritus [18].
Miscellaneous Causes
Drug Reactions
Adverse cutaneous drug reactions can manifest as miliary dermatitis. Common culprits include antibiotics (particularly beta-lactams), non-steroidal anti-inflammatory drugs (NSAIDs), and topical preparations. A thorough drug history is essential in all cases.
Endocrine Disorders
While less common than hypersensitivity disorders, endocrine diseases can occasionally present with miliary dermatitis. Hyperthyroidism has been associated with miliary dermatitis and other dermatological signs, likely due to increased metabolic rate and altered skin barrier function [26]. Hypothyroidism is rare in cats but can also cause skin changes.
Paraneoplastic Syndromes
Rarely, miliary dermatitis can be a paraneoplastic manifestation of internal neoplasia. Thymoma, for example, has been associated with exfoliative dermatitis in cats, which may present with miliary features [53]. Cutaneous T-cell lymphoma (mycosis fungoides) can also mimic inflammatory dermatoses [11].
Diagnostic Approach
A systematic, stepwise diagnostic approach is essential for identifying the underlying cause of miliary dermatitis and guiding appropriate treatment.
History and Signalment
A thorough history should include:
- Signalment: Age, breed, sex. Certain breeds (e.g., Siamese, Devon Rex) may be predisposed to allergic conditions.
- Onset and progression: Age at first signs, seasonal vs. non-seasonal pattern, duration of current episode.
- Pruritus assessment: Severity (using a pruritus Visual Analog Scale or pVAS), distribution, and response to previous treatments.
- Environmental history: Indoor vs. outdoor access, exposure to other animals, recent travel, household changes.
- Dietary history: Current and previous diets, treats, supplements, and table foods.
- Flea control history: Products used, frequency of application, and compliance.
- Medical history: Concurrent diseases, previous diagnoses, current and past medications.
Physical Examination
A complete physical examination should be performed, paying particular attention to:
- Skin and coat: Distribution and morphology of lesions, presence of alopecia, scaling, crusting, or lichenification.
- Ears: Otoscopic examination for evidence of otitis externa, ear mites, or ceruminous gland hyperplasia.
- Lymph nodes: Palpation for lymphadenopathy.
- Oral cavity: Examination for eosinophilic granuloma complex lesions (indolent ulcers, eosinophilic granulomas).
- General health: Body condition score, hydration status, and presence of any systemic abnormalities.
Diagnostic Tests
Basic Diagnostic Tests
Flea Combing: A fine-toothed flea comb should be used to search for adult fleas, flea faeces ("flea dirt"), and other ectoparasites. The dorsal lumbosacral region and tail head are the most productive areas.
Skin Scrapings: Superficial and deep skin scrapings should be performed to identify mites (Cheyletiella, Notoedres, Demodex).
Cytology: Impression smears, tape preparations, or swabs from skin lesions and ear canals should be examined for bacteria, yeast (Malassezia), and inflammatory cells [48].
Dermatophyte Culture: Hair plucks and skin scrapings should be submitted for fungal culture if dermatophytosis is suspected. Wood's lamp examination can be a useful screening tool but is not definitive (only 50% of M. canis strains fluoresce) [13].
Advanced Diagnostic Tests
Dietary Elimination Trial: A strict dietary elimination trial is the gold standard for diagnosing food hypersensitivity. A novel protein or hydrolysed protein diet should be fed exclusively for 8-12 weeks. If clinical signs resolve, a challenge with the original diet is performed to confirm the diagnosis [8][10].
Allergen-Specific IgE Testing: Serum allergen-specific IgE testing can support a diagnosis of atopic dermatitis. However, results must be interpreted cautiously as false positives and negatives occur. Intradermal skin testing is considered more accurate but is less commonly performed in cats [16][58].
Skin Biopsy: Histopathological examination of skin biopsies can help differentiate between various causes of miliary dermatitis and rule out neoplastic conditions. Characteristic findings include superficial perivascular eosinophilic dermatitis, epidermal spongiosis, and crusting [30].
Endocrine Testing: Serum total T4 (thyroxine) and free T4 levels should be measured if hyperthyroidism is suspected. Thyroid-stimulating hormone (TSH) testing may be helpful in diagnosing hypothyroidism [26].
Diagnostic Algorithm
A practical diagnostic algorithm for feline miliary dermatitis includes:
- Step 1: Rule out ectoparasites (flea combing, skin scrapings, ear swabs).
- Step 2: Rule out infectious causes (dermatophyte culture, cytology).
- Step 3: Implement strict flea control for 6-8 weeks.
- Step 4: If no response, perform dietary elimination trial for 8-12 weeks.
- Step 5: If no response, consider atopic dermatitis and perform allergen testing.
- Step 6: If still unresolved, consider skin biopsy and endocrine testing.
Treatment and Management
Treatment of miliary dermatitis must address both the underlying cause and the symptomatic pruritus. A multimodal approach is often necessary for optimal outcomes.
Addressing the Underlying Cause
Flea Control
For flea allergy dermatitis, rigorous flea control is essential. This involves:
- Adulticide treatment: Monthly application of an isoxazoline (e.g., fluralaner, afoxolaner, sarolaner) or other approved adulticide to all pets in the household.
- Environmental control: Regular vacuuming, washing pet bedding in hot water, and use of environmental flea control products (insect growth regulators such as lufenuron or pyriproxyfen).
- Duration: Flea control should be maintained year-round in endemic areas. Clinical improvement may take 4-8 weeks [7][15].
Dietary Management
For food hypersensitivity, the offending ingredient(s) must be identified and eliminated from the diet. This requires:
- Strict elimination trial: Feeding a novel protein or hydrolysed protein diet exclusively for 8-12 weeks.
- Challenge phase: If clinical signs resolve, reintroduce the original diet to confirm the diagnosis.
- Long-term management: Feed a diet free of the offending ingredient(s). Commercial or home-cooked diets may be used under veterinary guidance [8][21].
Allergen-Specific Immunotherapy (ASIT)
For feline atopic dermatitis, allergen-specific immunotherapy (allergy shots or sublingual immunotherapy) can be effective in reducing clinical signs. ASIT works by inducing immunological tolerance to the offending allergens. Response rates vary but are generally reported at 50-75% [6][58].
Symptomatic Treatment
Glucocorticoids
Corticosteroids are effective for rapid control of pruritus and inflammation in miliary dermatitis. However, their use should be reserved for short-term management while the underlying cause is being identified and addressed.
- Prednisolone: 1-2 mg/kg orally every 12-24 hours, tapered to the lowest effective dose.
- Methylprednisolone: 0.5-1 mg/kg orally every 12-24 hours.
- Triamcinolone: 0.1-0.2 mg/kg orally every 24 hours.
Long-term use of corticosteroids is associated with significant adverse effects, including polyuria, polydipsia, polyphagia, diabetes mellitus, and immunosuppression. Therefore, they should be used judiciously and for the shortest duration possible [58].
Cyclosporine (Atopica)
Cyclosporine is a calcineurin inhibitor that modulates T-cell activity and is effective for controlling pruritus in allergic cats. The typical dose is 5-7 mg/kg orally every 24 hours. Clinical improvement may take 4-6 weeks. Common side effects include vomiting, diarrhoea, and anorexia. Cyclosporine is generally well tolerated for long-term use [58].
Antihistamines
Antihistamines have limited efficacy in cats compared to dogs but may provide some benefit in mild cases or as adjunctive therapy.
- Cetirizine: 1 mg/kg orally every 24 hours.
- Chlorpheniramine: 2-4 mg/cat orally every 12 hours.
- Hydroxyzine: 5-10 mg/cat orally every 8-12 hours.
Essential Fatty Acids (EFAs)
Omega-3 and omega-6 fatty acid supplementation can improve skin barrier function and reduce inflammation. Studies have shown that evening primrose oil and fish oil can be beneficial in managing miliary dermatitis [29][31][33]. EFAs are generally safe and can be used as adjunctive therapy.
Topical Therapy
- Antiseptic shampoos: Chlorhexidine, miconazole, or ketoconazole shampoos can help control secondary bacterial and yeast infections.
- Moisturizers: Leave-on conditioners or sprays can improve skin barrier function.
- Topical glucocorticoids: Hydrocortisone aceponate (Cortavance) can be used for localized lesions.
Novel and Emerging Therapies
JAK Inhibitors
Janus kinase (JAK) inhibitors, such as oclacitinib (Apoquel), are increasingly used in feline dermatology. While oclacitinib is not yet approved for cats in all regions, studies suggest it can be effective for controlling pruritus in allergic cats. The dose is typically 0.4-0.6 mg/kg orally every 12 hours for 14 days, then every 24 hours for maintenance [56].
Biologics
Monoclonal antibodies targeting interleukin-31 (IL-31), such as lokivetmab (Cytopoint), have shown promise in dogs but are not yet approved for cats. Research is ongoing [56].
Vitamin C
A recent study investigated the potential benefits of vitamin C as an adjunctive treatment for feline atopic dermatitis. The study found that cats receiving methylprednisolone combined with vitamin C (25-75 mg/kg) showed a more rapid decrease in pruritus and skin lesion scores compared to those receiving methylprednisolone alone [58]. While the long-term efficacy remains uncertain, vitamin C may serve as a supportive therapy.
Management of Secondary Infections
Secondary bacterial and yeast infections should be treated concurrently with the underlying cause.
- Bacterial pyoderma: Systemic antibiotics (e.g., cefovecin, amoxicillin-clavulanate) based on culture and sensitivity.
- Malassezia dermatitis: Topical antifungal therapy (ketoconazole, miconazole) or systemic azoles (itraconazole, fluconazole) for severe cases [48].
Prognosis and Long-Term Management
The prognosis for miliary dermatitis depends on the underlying cause. With appropriate identification and management, most cases can be well controlled.
- Flea allergy dermatitis: Excellent prognosis with consistent flea control.
- Food hypersensitivity: Good prognosis with dietary avoidance.
- Atopic dermatitis: Fair to good prognosis with multimodal therapy, including ASIT.
- Ectoparasite infestations: Excellent prognosis with appropriate antiparasitic treatment.
- Infectious causes: Good prognosis with appropriate antimicrobial therapy.
Long-term management requires:
- Regular veterinary follow-up: To monitor response to treatment and adjust therapy as needed.
- Consistent flea control: Year-round in endemic areas.
- Dietary compliance: Strict avoidance of offending ingredients.
- Environmental control: Minimizing exposure to allergens.
- Owner education: Understanding the chronic nature of the condition and the need for ongoing management.
Prevention
Prevention of miliary dermatitis focuses on minimizing exposure to known triggers.
- Flea control: Year-round flea prevention for all pets in the household.
- Dietary management: Feeding a balanced, high-quality diet and avoiding unnecessary dietary changes.
- Environmental control: Regular cleaning, vacuuming, and air filtration to reduce allergen exposure.
- Stress reduction: Minimizing environmental stressors that can exacerbate pruritus.
Special Considerations
Breed Predispositions
Certain cat breeds may be predisposed to allergic conditions, including miliary dermatitis.
- Siamese, Devon Rex, and Cornish Rex: Higher risk of atopic dermatitis.
- Persian and Himalayan: May be predisposed to dermatophytosis.
- Abyssinian: Higher risk of food hypersensitivity.
Age Considerations
- Kittens (< 1 year): More likely to have dermatophytosis, ectoparasite infestations, or food hypersensitivity.
- Young adults (1-5 years): Typical age of onset for atopic dermatitis and flea allergy.
- Senior cats (> 10 years): Consider endocrine disorders (hyperthyroidism) and neoplasia.
Zoonotic Potential
Some causes of miliary dermatitis are zoonotic and can affect human contacts.
- Dermatophytosis: Highly contagious to humans, especially children and immunocompromised individuals.
- Cheyletiellosis: Can cause transient, pruritic dermatitis in humans.
- Notoedric mange: Can cause papular dermatitis in humans.
- Flea bites: Can cause allergic reactions in sensitized individuals [51].
Regional Variations
North America
Flea allergy dermatitis is the most common cause of miliary dermatitis in North America, particularly in the southeastern United States. The cat flea (Ctenocephalides felis) is the predominant species. The American Veterinary Medical Association (AVMA) and American Animal Hospital Association (AAHA) recommend year-round flea control for all cats, especially those with allergic skin disease.
Europe
The European Scientific Counsel for Companion Animal Parasites (ESCCAP) provides guidelines for flea control in Europe. The cat flea is also the primary species, but the dog flea (Ctenocephalides canis) and hedgehog flea (Archaeopsylla erinacei) can also be involved. Regional variations in climate affect flea seasonality.
Australia
Flea allergy dermatitis is highly prevalent in Australia, particularly in coastal regions. The cat flea is the dominant species. The Australian Veterinary Association (AVA) emphasizes the importance of year-round flea control. Cheyletiella infestations are also common in some areas.
Canada
Flea allergy dermatitis is less common in Canada due to colder winters, but it is still a significant problem in warmer months and in indoor environments. The Canadian Veterinary Medical Association (CVMA) recommends flea control based on regional risk assessment.
Frequently Asked Questions (FAQs)
Q: Can miliary dermatitis be cured? A: Miliary dermatitis is a reaction pattern, not a disease itself. The underlying cause (e.g., flea allergy, food hypersensitivity) can often be managed effectively, but many cats require lifelong treatment to control clinical signs.
Q: Is miliary dermatitis contagious to humans or other pets? A: The condition itself is not contagious, but some underlying causes (e.g., dermatophytosis, Cheyletiella mites, fleas) can be transmitted to humans and other animals.
Q: How long does it take for miliary dermatitis to resolve with treatment? A: Resolution time depends on the underlying cause. With appropriate treatment, clinical improvement is often seen within 2-4 weeks. Complete resolution may take 8-12 weeks.
Q: Can stress cause miliary dermatitis in cats? A: Stress can exacerbate pruritus in cats with underlying allergic conditions, but it is rarely the sole cause of miliary dermatitis.
Q: What is the difference between miliary dermatitis and eosinophilic granuloma complex? A: Miliary dermatitis is characterized by small, crusted papules, while eosinophilic granuloma complex includes three distinct lesions: indolent ulcers (on the lip), eosinophilic plaques (raised, well-circumscribed lesions), and eosinophilic granulomas (linear or nodular lesions). These conditions can overlap [20][30].
Conclusion
Feline miliary dermatitis is a common and often frustrating condition for both veterinarians and cat owners. Its successful management requires a systematic diagnostic approach to identify the underlying cause, followed by targeted therapy and long-term monitoring. While many cases are chronic, most cats can achieve good quality of life with appropriate treatment.
The key to success lies in:
- Thorough history and physical examination
- Systematic diagnostic testing
- Addressing the underlying cause
- Multimodal symptomatic therapy
- Owner education and compliance
By adhering to these principles, veterinary professionals can effectively manage miliary dermatitis and improve the lives of affected cats and their families.
References
[1] Jiménez B. Otitis and miliary dermatitis in a cat infected with Otodectes cynotis. Journal. 2018.
[2] Grant D. Miliary dermatitis in the cat. Journal. 1991.
[3] Breathnach R, Shipstone M. Chapter 48 – The cat with miliary dermatitis. Journal. 2006.
[4] Breathnach R, Shipstone M. Chapter 49 – The cat with pruritus without miliary dermatitis. Journal. 2006.
[5] Bellone AG, Chard WG, Gray JL, et al. Eosinophilic papulocrustous dermatitis (miliary dermatitis) and eosinophilic inflammatory bowel disease in two cats. New Zealand Veterinary Journal. 1995.
[6] Ravens PA, Xu B, Vogelnest L. Feline atopic dermatitis: a retrospective study of 45 cases (2001-2012). Veterinary Dermatology. 2014.
[7] Sampeck B, Sutherland CJ, Canfield M, et al. Use of a modified SCORFAD scale to define localised reaction patterns associated with a flea burden in cats. Veterinary Dermatology. 2024.
[8] Bryan J, Frank L. Food Allergy in the Cat: A Diagnosis by Elimination. Journal of Feline Medicine and Surgery. 2010.
[9] Nuttall T, van Steen R, Cawood M, et al. FC-49 Feline Dermatitis Extent and Severity Index: a pilot study. Journal. 2004.
[10] Guaguère É, Prélaud P. Food hypersensitivity in the cat. Journal. 2009.
[11] Wood C, Almes K, Bagladi-Swanson M, et al. Sézary syndrome in a cat. Journal of the American Animal Hospital Association. 2008.
[12] Herrtage M, Barnett K, Macdougall D. Diabetic retinopathy in a cat with megestrol acetate-induced diabetes. Journal. 1985.
[13] Pin D. Non-dermatophyte Dermatoses Mimicking Dermatophytoses in Animals. Mycopathologia. 2016.
[14] Koutinas A, Papazahariadou M, Rallis T, et al. Flea species from dogs and cats in northern Greece: environmental and clinical implications. Veterinary Parasitology. 1995.
[15] Noli C. Flea Biology, Allergy and Control. Journal. 2020.
[16] Diesel A, DeBoer D. Serum allergen-specific immunoglobulin E in atopic and healthy cats: comparison of a rapid screening immunoassay and complete-panel analysis. Veterinary Dermatology. 2011.
[17] Diesel A. Feline Atopic Syndrome: Epidemiology and Clinical Presentation. Feline Dermatology. 2020.
[18] Diesel A. When is Pyoderma not Pyoderma? Journal. 2017.
[19] Nagata M, Ishida T. Cutaneous reactivity to mosquito bites and its antigens in cats. Veterinary Dermatology. 1997.
[20] Forsythe P. Feline eosinophilic dermatoses Part 1: Aetiology, clinical signs and investigation. Journal. 2011.
[21] Roudebush P, McKeever P. Evaluation of a Commercial Canned Lamb and Rice Diet for the Management of Cutaneous Adverse Reactions to Food in Cats. Journal. 1993.
[22] Foil C. Differential diagnosis of feline pruritus. Veterinary Clinics of North America: Small Animal Practice. 1988.
[23] Gosselin Y, Chalifoux A, Papageorges M. The use of megestrol acetate in some feline dermatological problems. Canadian Veterinary Journal. 1981.
[24] Harvey R. Investigation of feline alopecia. A & A Practice. 1990.
[25] Muller A, Guaguère É, Degorce-Rubiales F, et al. P-59 Three cases of opportunistic dermatoses associated with internal diseases in cats. Journal. 2004.
[26] Erdogan S, Ural K, Erdoğan H. Hypo- versus hyper-thyroidism in 2 cats: the culprit for miliary dermatitis/hypersensitivity versus growth retardation. Journal. 2019.
[27] Oh J, Kim S, Kim M, et al. Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine. 2025.
[28] Patel A. Feline miliary dermatitis. Journal. 2013.
[29] Harvey RG. Management of feline miliary dermatitis by supplementing the diet with essential fatty acids. Veterinary Record. 1991.
[30] Gross TL, Kwochka KW, Kunkle GA. Correlation of histologic and immunologic findings in cats with miliary dermatitis. Journal of the American Veterinary Medical Association. 1986.
[31] Harvey R. Effect of varying proportions of evening primrose oil and fish oil on cats with crusting dermatosis ('miliary dermatitis'). Veterinary Record. 1993.
[32] Roosje P, Willemse T. Cytophilic antibodies in cats with miliary dermatitis and eosinophilic plaques: passive transfer of immediate-type hypersensitivity. Veterinary Quarterly. 1995.
[33] Lechowski R, Sawosz E, Kluciński W. The effect of the addition of oil preparation with increased content of n-3 fatty acids on serum lipid profile and clinical condition of cats with miliary dermatitis. Zentralblatt für Veterinärmedizin Reihe A. 1998.
[34] Jackson A, Foster A. Management of feline miliary dermatitis: a clinical update. A & A Practice. 2006.
[35] Mrcvs JCVM. Feline miliary dermatitis. Journal. 2007.
[36] Klisić A, Bakić M, Karanikolić V. Comparative Analysis of Redox Homeostasis Biomarkers in Patients with Psoriasis and Atopic Dermatitis. Antioxidants. 2023.
[37] Weidinger S, Blauvelt A, Papp K, et al. Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis. Journal of Allergy and Clinical Immunology. 2024.
[38] Rübe C, Freyter B, Tewary G, et al. Radiation Dermatitis: Radiation-Induced Effects on the Structural and Immunological Barrier Function of the Epidermis. International Journal of Molecular Sciences. 2024.
[39] Polaskey M, Chang CH, Daftary K, et al. The Global Prevalence of Seborrheic Dermatitis: A Systematic Review and Meta-Analysis. JAMA Dermatology. 2024.
[40] Narla S, Chiesa Fuxench ZC, Abuabara K, et al. What Does Long-Term Control in Atopic Dermatitis Look Like? Dermatitis. 2025.
[41] Bangert C, Alkon N, Chennareddy S, et al. Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells. Nature Communications. 2024.
[42] Weber B, Karels S, Hylwa SA, et al. Contact Urticaria Testing at a Specialized Contact Dermatitis Clinic: Our Experience Over 5 Years. Dermatitis. 2025.
[43] Aerts O, Rustemeyer T, Belloni-Fortina A, et al. Variability in Paediatric Patch Test Practices Across Europe: A Survey From the European Baseline Series (EBS) Working Party on Behalf of the European Society of Contact Dermatitis (ESCD). Contact Dermatitis. 2025.
[44] Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. The Lancet. 2017.
[45] Cespedes Zablah A, Griffin T, Lio P. Beyond Ultraviolet: A Scoping Review of Light Treatments in Atopic Dermatitis. Dermatitis. 2025.
[46] Youn CG, Bae G, Honari G, et al. Barriers to Health Care Affordability among Parents of Children with Atopic Dermatitis. Dermatitis. 2025.
[47] Huth N, Wenkel R, Roschanski N, et al. Prototheca zopfii Genotype 2-induced Nasal Dermatitis in a Cat. Journal of Comparative Pathology. 2015.
[48] Hobi S, Bęczkowski P, Mueller RS, et al. Malassezia dermatitis in dogs and cats. The Veterinary Journal. 2024.
[49] Chu DK, Schneider LC, Asiniwasis R, et al. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Annals of Allergy, Asthma & Immunology. 2023.
[50] DeKoven J, Warshaw E, Reeder M, et al. North American Contact Dermatitis Group Patch Test Results: 2019-2020. Dermatitis. 2023.
[51] Youssefi M, Ebrahimpour S, Rezaei M, et al. Dermatitis caused by Ctenocephalides felis (cat flea) in human. Caspian Journal of Internal Medicine. 2014.
[52] Ng KL, Tam M, Nixon R. Allergic Contact Dermatitis to Coumarin in a Tinted Moisturiser Containing Melilotus officinalis (Sweet Clover) Extract. Contact Dermatitis. 2025.
[53] Cavalcanti J, Pereira de Moura M, Oliveira Monteiro F. Thymoma associated with exfoliative dermatitis in a cat. Journal of Feline Medicine and Surgery. 2014.
[54] De Guzman CD, Jordan K, Le NT, et al. Improved Investigator Global Assessment, Allergic Contact Dermatitis-11, Dermatology Life Quality Index, and Global Quality of Life and Severity Scores after Patch Testing in Dermatitis Patients. Dermatitis. 2026.
[55] Alley D, Abi HA, Hylwa SA, et al. Eyelid Dermatitis: A 5-Year Retrospective Review from a Metropolitan Contact Dermatitis Clinic. Dermatitis. 2026.
[56] Chu A, Wong M, Rayner D, et al. Systemic treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials. Journal of Allergy and Clinical Immunology. 2023.
[57] Rydz E, Walld R, Quinn E, et al. Assessing contact dermatitis risk among Manitoba workers in the Manitoba Occupational Disease Surveillance System. Contact Dermatitis. 2024.
[58] Katanalp ÖF, Telek N, Güneş A. Feline Atopic Dermatitis.